baber/WOPTO huggingface dataset:
Patent FI-89370-B (FI)
Inventor: LASSALLE DOMINIQUE
IPC: C08F10/00
Filed: 1986-10-08
Granted: 1993-06-15
Abstract: The present invention relates to a process for the polymerisation or copolymerisation of alpha-olefins in the presence of a Ziegler-Natta catalyst system comprising on the one hand a catalyst solid comprising compounds of halogens, transition metals of Groups lV, V, VI of the Periodic Table of Elements, magnesium and optionally aluminium, free from a metal/carbon bond and on the other hand a catalyst consisting of organometallic compounds of metals of Group II or III of the said Table. This process is characterised in that before its use in polymerisation or copolymerisation, the catalyst solid is treated by water in a given quantity, this treatment making it possible to improve the conditions for obtaining polymers, particularly in a process of polymerisation or copolymerisation in the gas phase.
Patent FI-101632-B (FI)
Inventor: BURNETTE III WALTER NEAL
IPC: C12P15/00
Filed: 1989-05-03
Granted: 1998-07-31
Abstract: The development of subunits and subunit analogs of the Bordetella exotoxin by recombinant DNA techniques provides vaccine products that retain their biological activity, are highly immunogenic, and can confer protection against disease challenge. Genetically-engineered modifications of the subunits can result in products that retain immunogenicity, yet are free of enzymatic activity associated with toxin of reactogenicity.
Patent FI-102724-B (FI)
Inventor: JANOFF ANDREW STUART
IPC: A61K/
Filed: 1989-09-04
Granted: 1999-02-15
Abstract: Methods and compositions are described for nonliposomal lipid complexes in association with toxic hydrophobic drugs such as the polyene antibiotic amphotericin B. Lipid compositions are preferably a combination of the phospholipids dimyristoylphosphatidylcholine (DMPC) and dimyristoylphosphatidylglycerol (DMPG) in about a 7:3 mole ratio. The lipid complexes contain a bioactive agent, and may be made by a number of procedures, at high drug:lipid ratios. These compositions of high drug:lipid complexes (HDLCs) may be administered to mammals such as humans for the treatment of infections, with substantially equivalent or greater efficacy and reduced drug toxicities as compared to the drugs in their free form. Also disclosed is a novel liposome-loading procedure, which may also be used in the formation of the HDLCs.
Patent FI-106382-B (FI)
Inventor: ALBIZZATI ENRICO
IPC: C08F4/658
Filed: 1991-03-27
Granted: 2001-01-31
Abstract: Catalyst components for the polymerization of olefins comprising a titanium halide or alkoxyhalide and an electron-donor compound selected from ethers having two or more ether groups and containing at least one heteroatom selected from the group consisting of N, S, P, Si, non-ether O and halogen atoms or at least one double bond, or both at least one heteroatom and at least one double bond, supported on a magnesium halide in active form. Catalysts obtained from said catalyst components and an Al-alkyl compound.
Patent FI-95339-B (FI)
Inventor: KAUPPI HANNA-MARIA
IPC: H04W68/08
Filed: 1992-09-18
Granted: 1995-09-29
Abstract: In a cellular radio network in which mobile stations roam, in addition to location updating of each mobile station with the accuracy of one location area, a so-called temporary subscriber-specific paging area is determined. Each mobile station initiates the determining of the temporary paging area in the subscriber data base of the cellular radio network after being located in a cell for a sufficiently long period. The temporary paging area is smaller than the location area (e.g., one cell and possibly at least one adjacent cell), and thus the paging of a mobile station can be focused on a small area, i.e., the temporary paging area. It is thus unnecessary to page over the entire location area, and paging time can be reduced and capacity of the cellular radio network spared.
Patent FI-96837-B (FI)
Inventor: LINDSTRAND ULF
IPC: B65H49/38
Filed: 1993-11-25
Granted: 1996-05-31
Abstract: PCT No. PCT/SE92/00351 Sec. 371 Date Nov. 22, 1993 Sec. 102(e) Date Nov. 22, 1993 PCT Filed Mar. 25, 1992 PCT Pub. No. WO92/21604 PCT Pub. Date Dec. 10, 1992.A tool mounts a parcel containing a coil of a cable, for instance, a sleeve for the cable, and two protective rings at the sides of the coil, the tool having two wheel-shaped side supports including one larger and one smaller circle segment having opposite dividing edges, the circle segments being capable to be coupled and locked to each other. The side supports are provided with concentric centering elements to center the sleeve, the dividing edges being provided radially outside the centering elements of the side supports for dividing the distance between the centering element and the peripheral edge element in a ratio of from 1:1 to 1:3. The dividing edge of the larger circle segment is provided at a radial distance from the center of the side support that is less than the radius of the parcel.
Patent FI-106854-B (FI)
Inventor: FISHER MATTHEW JOSEPH
IPC: C07D311/22
Filed: 1994-07-22
Granted: 2001-04-30
Abstract: This invention relates to certain bicyclic compounds having a nucleus formed of two fused six membered rings, for example, isoquinoline, isoquinolone, tetrahydronaphthalene, dihydronaphthalene, or tetralone, substituted with both basic and acidic functionality, which are useful in inhibition of platelet aggregation.
Patent FI-113904-B (FI)
Inventor: GOSS JOHN D
IPC: G21F5/015
Filed: 1994-09-19
Granted: 2004-06-30
Abstract: PCT No. PCT/US93/02621 Sec. 371 Date Dec. 10, 1993 Sec. 102(e) Date Dec. 10, 1993 PCT Filed Mar. 22, 1993 PCT Pub. No. WO93/19473 PCT Pub. Date Sep. 30, 1993.A nuclear gauge (7) for making measurements of traveling webs (11) in continuous sheet-making processes includes an enclosure (20), an encapsulated nuclear source (28), and a wheel-like member (10) mounted in the enclosure means for carrying the encapsulated nuclear source between two angularly-displaced positions. The first of the angularly-displaced positions is the position whereat the encapsulated nuclear source makes measurements of a web that travels past the gauge, and the second position is the location whereat the encapsulated nuclear source faces a sidewall of the enclosure means at a location remote from the first position. The nuclear gauge also has an aperture (16) which is formed through the enclosure for providing a window through which the encapsuled nuclear source, when located in the first position, can emit radiation onto a web that travels past the window.
Patent FI-112747-B (FI)
Inventor: DEAN RICHARD F
IPC: H04B7/02
Filed: 1995-04-24
Granted: 2003-12-31
Abstract: A distributed antenna system is utilized in a system for providing multipath signals which facilitate signal diversity for enhanced system performance. Each node of the antenna comprises more than one antenna. Each antenna at a common node provides a path having a different delay to the base station.
Patent FI-108225-B (FI)
Inventor: GRUE-SOERENSEN GUNNAR
IPC: A61P17/00
Filed: 1995-06-16
Granted: 2001-12-14
Abstract: PCT No. PCT/DK93/00425 Sec. 371 Date Apr. 11, 1995 Sec. 102(e) Date Apr. 11, 1995 PCT Filed Dec. 17, 1993 PCT Pub. No. WO94/14766 PCT Pub. Date Jul. 7, 1994The present invention relates to compounds of the following formula   <IMAGE>   in which Y is sulfur, S(O), or S(O)2; R stands for C1-C3 alkyl, or can form a C3-C8 carbocyclic ring. Q is a C1-C8 hydrocarbylene diradical; and derivatives thereof. The compounds can be made by reacting a 20(S)-formyl vitamin D derivative with tert-butyl hypochlorite to form the corresponding acid chloride which is then reacted with potassium O-ethyl dithiocarbonate followed by photochemical reaction and decarbonylation, treatment with aminoethanol, and conversion to the 22-thiol. The 22-thiol is then alkylated to form the desired sidechain. The compounds show antiinflammatory and immunomodulating effects. They also exhibit strong activity in inducing differentiation and inhibiting undesirable proliferation of certain cells.
Patent FI-112647-B (FI)
Inventor: BAEHR ALBERT
IPC: B01D25/127
Filed: 1995-11-30
Granted: 2003-12-31
Abstract: In a process and assembly to de-water sludge (9) and similar substances, the sludge is charged into an enclosed main chamber (20) incorporating a filter surface (24, 25), and subjected to hydrostatic pressurisation. Following expulsion of the water, the chamber is opened and the filter cake removed on the filters (24, 25). The novelty is that before de-watering in the main chamber, the sludge charge is first held in an intermediate chamber (3), linked to the main chamber (20), whose inlet (6) is then blocked while the sludge is subjected to hydrostatic pressure which forces it into the main chamber (20). The incoming sludge is retained in a holding tank (5) until required for treatment.
Patent FI-116362-B (FI)
Inventor: HAHN RAINER
IPC: A61C5/40
Filed: 1996-08-26
Granted: 2005-11-15
Abstract: PCT No. PCT/EP95/00710 Sec. 371 Date Aug. 28, 1996 Sec. 102(e) Date Aug. 28, 1996 PCT Filed Feb. 27, 1995 PCT Pub. No. WO95/22938 PCT Pub. Date Aug. 31, 1995For ultrasonic preparation of hard or soft tissues or of tissue replacement material a apparatus is proposed comprising a hand piece (10), which includes an ultrasonic vibration generator (16), an ultrasonics deflecting head (28) as well as a tool (36) carried by the output member of the deflecting head. An abrasive treatment medium (48) is supplied to the working region defined between the tool (36) and the material (66) to be prepared. Thus even in places, which are difficult to access, cavities can be produced in dental or bone tissue in a gentle and precise manner.
Patent HU-189969-B (HU)
Title: Ceramic covering element for high-pressure discharge lamps
Inventor: KAJIHARA TEKEHIRO
IPC: H01J61/36
Filed: 1985-04-02
Abstract: A ceramic envelope device for a high-pressure metal-vapor discharge lamp, having a translucent ceramic tube (12), a pair of end caps (14) closing opposite ends of the ceramic tube, and a pair of opposed discharge electrodes (16) each of which is supported at its one end by the corresponding end cap such that the other end of the electrode protrudes from an inner surface of the corresponding end cap in the longitudinal direction of the ceramic tube. In order to prevent the phenomenon of "arc-back" from the electrode to the end cap, the end caps (14) are electrically conductive, and are covered at their inner surfaces with an electrical insulator (20).
Patent HU-215484-B (HU)
Inventor: BOWLES SYLVIA JEAN
IPC: C11D1/12
Filed: 1991-11-20
Abstract: A találmány átlátszatlan tisztító főrmatest, amely két fázisból,nevezetesen egy, a tisztító főrmatest 12 mm vastagságú mintáján 12 mm penetrációsértékű, és 25 mm vastagságú mintáján 0–12 mm penetrációs értékű, 25řC-őn lágy vagy főlyóképes vizes fázisból, és a ti ztító főrmatest3–75 térfőgat%-át kitevő, semlegesített karbőnsavból felépülő, merevvázszerkezetű, kristályős fázisból áll, a semlegesített karbőnsavlítiűmmal és/vagy nátriűmmal semlegesített mőnők rbőnsav – szappan –és/vagy dikarbőnsav vagy keverékük, tővábbá a mőnőkarbőnsavalkilénlánca 12–24 szénatőmős, a dikarbőnsav alkilénlánca 12–18szénatőmős, és a karbőnsav legalább 80%-ban alkilcsőpőr őkattartalmaz, és ismérve, hőgy a merev vázszerkezetű, kristályős fázis asemlegesített mőnő- és/vagy dikarbőnsav megnyúlt, fénydiffrakciós, 400nm-nél hősszabb kristályainak összefőnódó, nyitőtt, h rőmdimenzióshálózatát tartalmazza. A találmány tárgyát képezi a főrmatestekelőállítására szőlgáló eljárás is, amely sőrán az őlvadt főlyadékhőz –a szerszámba öntést megelőzően – kristályősődást serkentő sókat adnak. ŕ
Patent HU-183963-B (HU)
Inventor: KOEVESDI JANOS
IPC: B65D5/48
Filed: 1982-06-15
Abstract: Die Erfindung betrifft eine Knotenpunktausbildung zum Verbinden quer zueinanderstehender Platten mit dem Ziel, ein sicheres Zusammenfuegen der Platten mit geringem technologischen Aufwand zu gewaehrleisten. Der Erfindung liegt die Aufgabe zugrunde, eine Knotenpunktausbildung zu schaffen, die leicht loesbar ist, jedoch ein unerwuenschtes Auseinanderfallen beseitigt. Erfindungsgemaess wird die Aufgabe dadurch geloest, dass bei den miteinander zu verbindenden Platten in dem Spalt der einen Platte 1 eine Erweiterung (5) und in dem vollen Teil der anderen Platte (2) eine Ausnehmung (6) ausgebildet ist oder die Spalte beider Platten (1; 2) mindestens eine Erweiterung (5) aufweisen und die Ausnehmungen (6) und/oder Erweiterungen (5) sich derart anpassen, dass sie zur Aufnahme eines Verbindungsstueckes, vorzugsweise einer Kugel (3a) oder eines Prismas (3b) geeignet sind.
Patent HU-186442-B (HU)
Inventor: PIROS ZOLTAN
IPC: A61K9/18
Filed: 1981-11-24
Abstract: A találmány tárgya eljárás gyógyszerkészítésre alkalmas homogén kristályformájú és felületű részecskék előállítására, oly módon, hogy alkoholos vagy vizes diszperziós közegben jelenlévő különböző kristályformával és felülettel rendelkező részecskéket fluidizációs technikával ütköztetve felületkezeljük 0,1-4 1/perc diszperzió adagolási sebesség, 1000-5000 ms/óra fluidizáló levegősebesség, 4 bar porlaeztónyomás mellett. 185142 -1-
Patent HU-194278-B (HU)
Title: Process for production of medical compounds containing as active substance bicyclic dipeptides and of the active substance
Inventor: URBACH HANSJOERG
IPC: C07D215/227
Filed: 1982-12-28
Abstract: The invention relates to cis, exo- and trans-compounds of the formula I <IMAGE> in which n denotes 0, 1 or 2, R1 denotes hydrogen, alkyl which can optionally be substituted by amino, acylamino or benzoylamino, alkenyl, cycloalkyl, cycloalkenyl, cycloalkylalkyl, aryl or partially hydrogenated aryl, which in each case can be substituted by alkyl, alkoxy or halogen, arylalkyl which can be substituted in the aryl radical as defined above, a mono- or bicyclic S- or O- and/or N-heterocycle radical or a side chain of a naturally occurring amino acid, R2 denotes hydrogen, alkyl, alkenyl or arylalkyl, Y denotes hydrogen or hydroxyl, Z denotes hydrogen or Y and Z together denote oxygen and X denotes alkyl, alkenyl, cycloalkyl, aryl which can be mono-, di- or trisubstituted by alkyl, alkoxy, hydroxyl, halogen, nitro, amino, alkylamino, dialkylamino or methylenedioxy, or indol-3-yl, and their physiologically acceptable salts, a process for their preparation, compositions containing them and their use, and also novel bicyclic amino acids as intermediates and a process for their preparation.
Patent HU-203971-B (HU)
Inventor: RIDEOUT JANET LITSTER
IPC: A61K31/70
Filed: 1986-09-15
Abstract: A találmány szerint 3’-azido-3’-dezoxitimidint és acyclovir, α-interferon, dipiridamol, probenicid, dilazep vagy 6-[(4-nitro-benzil)-tio]-9-3-D-ribofuranozil- purin hatóanyagot szinergetikus arányban humán retrovíms fertőzések megelőzésére vagy kezelésére alkalmas gyógyászati készítményekké formálnak. A leírás terjedelme: 10 oldal HU 203 971 -1-
Patent HU-203396-B (HU)
Inventor: TOEROEK LASZLO
IPC: F04B43/12
Filed: 1988-11-18
Abstract: A találmány tárgya önfelszívó tömlőszivattyú, amely tömlőszivattyúban rugalmas, körívben meghajlítható, keresztmetszetében összenyomható tömlő (6), a tömlő (6) keresztmetszetének az összenyomására alkalmas nyomóelem, a nyomóelem mozgatására alkalmas, a tömlőszivattyú házában (1) elforgathatóan rögzített forgórész és a házban (1), a tömlőnek (6) a nyomóelemmel ellentétes oldalán, a tömlőnek (6) a nyomóelemmel történő összenyomására alkalmas támasz (5) van. A találmánynak az a lényege, hogy a forgórész a házban (1) elforgatható tengelyen (2) rögzített excentertárcsa (3), a nyomóelem az excentertárcsán (3) elforgathatóan elhelyezhető, az excentertárcsa (3) külső átmérőjével azonos íuratátmérőjű szabadonfutó tárcsa (4) és a támasz (5) a háznak (1) az excentertárcsa (3) tengelyével (2) koaxiális belső felülete, míg a tömlő (6) a szabadonfutó tárcsa (4) külső palástján csavarvonalban van felfektetve. (1. ábra) A’-A,   A-A2 CB   5 HU 203 396 B A leírás terjedelme: 3 oldal, 1 rajz -1-
Patent HU-203780-B (HU)
Title: Process for producing living liophylised vaccine against infecting bursitis
Inventor: PALYA VILMOS
IPC: A61K39/12
Filed: 1988-12-16
Abstract: For the prepn. of a lyophilised vaccine against contagious bursitis, a bursitis viral strain registered under No.NCAIM V(P) 001034 grown on a cell culture of chicken embryo fibroblast. At an optimum virus titre the viral fluid is collected and lyophilised in the presence of a protective colloid
Patent IT-1204097-B (IT)
Title: Welding wire feed system
Inventor: CHINI MARIO
IPC: B23K/
Filed: 1986-03-26
Granted: 1989-03-01
Abstract: The suit is made of a piece of material which can cover the body several times and provided with various fastening means which can be joined in many directions
Patent IT-1216265-B (IT)
Title: Antiandrogenic compsn.
Inventor: FEDERIGO SICUTERI
IPC: A61K/
Filed: 1986-09-09
Granted: 1990-02-22
Abstract: Indicator tube detects the presence, with a mimimum concn. of 5x10 power (-3) MG/L, of mixtures of 2,2'-dichlor-tri-ethylamine, methyl-bis-beta-chlor-ethylamine and 2,2',2-tri-chlor-tri-ethylamine. Tube contains a polyethylene insert (2), filler (3) contg. calcium chloride, and superimposed indicator layer (4) of a bismuth salt, pref. bismuth-iodide, and glass wool (5).
Patent LV-13966-B (LV)
Title: Linear peristaltic pump and pumping process
Inventor: LAPSA VIDEVUDS-ARIJS
IPC: F04B43/12
Filed: 2009-04-06
Abstract: The invention pertains to linear peristaltic pump containing an elastic hose included in four or more following chambers, where the working media - a gas or liquid is filled. The chambers through regulated valves are fitted at the output manifold of the pump, and they could be fitted also at the pump's input manifold. The working process of these valves is directed by a programmed regulation device. The working process of these pump consist of following operations: to pump out the working media of the chamber, to endure the low pressure or vacuum, to pump in and raise the compression and to endure the compression of the working media. The described working process as a wave is directed from the inlet of the first chamber in the direction to the outlet through the last chamber. By wave-like pressing and release the elastic hose the pumped material in the hose is transferred from the inlet fit to the outlet fit of the pump and the wavelength of the process is equal or more than the total length of four chambers.
Patent LV-10036-B (LV)
Title: Cosmetic for facial skin
Inventor: GERCIKOVS ILJA
Filed: 1992-06-20
Abstract: This invention refers to make-up products. The product contains a powdered basic substance (talc powder, stearin acid salt, kaolin, starch in certain mass proportions), and a binding agent composed of fat additives (mineral oils, emulsifier, plant extract, preserving agent, antioxidant, animal fat and/or fatty acids esters, silicone solution and/or lanoline derivative). As a plant extract, plantain, marjoram, and/or carrot oil extract, e.g., on a castor oil basis, is used. The product has good adhesive qualities, allowing qualitative application to the skin and it does not irritate the skin or make it dry, but softens it, thanks to optimal proportions of binding agent components and powdered basic substance components.
Patent LV-10198-B (LV)
Title: Pharmaceutical composition for induction of penis erection and use of the same
Inventor: THOMAS GERSTENBERG
IPC: A61K38/095
Filed: 1993-06-29
Abstract: The present invention provides methods and compositions for inducing penile erections, sufficient for vaginal penetration, in a human male suffering from impotence. When the impotence is substantially only neurogenic, psycogenic or neurogenic and psychogenic, a method of the invention comprises (A) administering to the male by intracavernosal injection peptide N-terminal histidine C-terminal methionineamide and (B) sexually stimulating the male. When the impotence is caused by severe atherosclerosis, a method of the invention comprises (A) administering to the male by intracavernosal injection an amount of a physiologically acceptable composition comprising (1) a neuropeptide selected from the group consisting of human vasoactive intestinal peptide and peptide N-terminal histidine C-terminal methionineamide and (2) an alpha-adrenergic blocker, such as phentolamine or prazosin, and (B) sexually stimulating the male. The invention also entails a physiologically acceptable composition suitable for use in inducing, upon administration by intracavernosal injection, an erection, sufficient for vaginal penetration, in a human male suffering from impotence, which is caused by severe atherosclerosis, which composition comprises (1) a neuropeptide selected from the group consisting of vasoactive intestinal peptide and peptide N-terminal histidine C-terminal methionineamide and (2) an alpha-adrenergic blocker, such as phentolamine or prazosin.
Patent LV-10370-B (LV)
Title: Method for preserving of forage
Inventor: JOUKO SETALA
IPC: A23K3/00
Filed: 1994-06-10
Abstract: The invention relates to a process of preserving forage, a Lactobacillus plantarum strain used in the process, the use of the strain in the preservation of forage, and forage preserved according to the invention. The bacterial strain is preferably used in combination with at least one other preservative, such as cellulase and organic acid and/or in combination with at least one other lactic acid bacterium.
Patent LV-11315-B (LV)
Title: Porous fillers for concrete and method for producing thereof
Inventor: ALEKSANDRS CUCUJEVS
IPC: C04B18/10
Filed: 1995-02-07
Abstract: The object of this invention is a concrete filler (pebbles) and its manufacturing method. Field of application: light concretes and products made from them.The concrete filler (pebbles) is produced out of dry peat ashes, by mixing with the mineral adhesion agent and an amount of water necessary for the process of granulation. In some cases, fine sawdust and other fine-grained porous materials could be added as a filler (<2.5mm). The concrete porous filler (pebbles) consists of: a mixture of ground and non-ground peat ashes (1:1/9:1) - 82/87%, Portland cement M400 - 13/18% free from additives. Pebble manufacturing technique: a portion of ashes is ground until the specific area of 4500 cm<2>/g is achieved. The ground ashes and Portland cement are fed into a mixing granulator and mixed together for 2-3 minutes. Then a portion of non-ground ashes is added, and mixing continues for another 1.5/2.0 minutes. The technological process water is added, and this mass is granulated for 2/10 minutes. The obtained filler grains (pebbles) are placed on a sifting rack for hardening under proper conditions or, also, in the heating chambers for thermal processing.